NCT00245921View on ClinicalTrials.gov

Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception

PHASE3CompletedINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Contraception
Interventions
DRUG

Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00245921 - Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception | Biotech Hunter | Biotech Hunter